Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate

KV Chalam, Vijay Khetpal, Chirag J PatelDepartment of Ophthalmology, University of Florida Jacksonville, FL, USAIntroduction: Pseudophakic cystoid macular edema is a common cause of poor vision after cataract surgery, and topical corticosteroids and nonsteroidal anti-inflammatory drugs are used for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chalam KV, Khetpal V, Patel CJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/1fb01691647247e4878168f7d59b23cd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1fb01691647247e4878168f7d59b23cd
record_format dspace
spelling oai:doaj.org-article:1fb01691647247e4878168f7d59b23cd2021-12-02T02:02:43ZSpectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate1177-54671177-5483https://doaj.org/article/1fb01691647247e4878168f7d59b23cd2012-01-01T00:00:00Zhttp://www.dovepress.com/spectral-domain-optical-coherence-tomography-documented-rapid-resoluti-a9120https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483KV Chalam, Vijay Khetpal, Chirag J PatelDepartment of Ophthalmology, University of Florida Jacksonville, FL, USAIntroduction: Pseudophakic cystoid macular edema is a common cause of poor vision after cataract surgery, and topical corticosteroids and nonsteroidal anti-inflammatory drugs are used for its treatment. We investigated the effectiveness of difluprednate (Durezol®, recently approved by the US Food and Drug Administration) in the treatment of cystoid macular edema, assisted with spectral domain optical coherence tomography (SD-OCT).Case report: A 63-year-old African-American woman presented 6 weeks after uneventful cataract surgery in her left eye with decreased vision and associated distortion of the central visual field. Fluorescein angiogram and SD-OCT confirmed pseudophakic cystoid macular edema. Difluprednate was topically administered twice daily and monitored with serial imaging. Resolution was noted after 1 month of topical therapy, with improvement in visual acuity and resolution of distortion.Conclusion: Difluprednate is an effective treatment for patients with severe pseudophakic cystoid macular edema. SD-OCT allows the physician to monitor resolution of the macular edema easily.Keywords: cystoid macular edema, difluprednate, spectral domain optical coherence tomography, pseudophakicChalam KVKhetpal VPatel CJDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2012, Iss default, Pp 155-158 (2012)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Chalam KV
Khetpal V
Patel CJ
Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate
description KV Chalam, Vijay Khetpal, Chirag J PatelDepartment of Ophthalmology, University of Florida Jacksonville, FL, USAIntroduction: Pseudophakic cystoid macular edema is a common cause of poor vision after cataract surgery, and topical corticosteroids and nonsteroidal anti-inflammatory drugs are used for its treatment. We investigated the effectiveness of difluprednate (Durezol®, recently approved by the US Food and Drug Administration) in the treatment of cystoid macular edema, assisted with spectral domain optical coherence tomography (SD-OCT).Case report: A 63-year-old African-American woman presented 6 weeks after uneventful cataract surgery in her left eye with decreased vision and associated distortion of the central visual field. Fluorescein angiogram and SD-OCT confirmed pseudophakic cystoid macular edema. Difluprednate was topically administered twice daily and monitored with serial imaging. Resolution was noted after 1 month of topical therapy, with improvement in visual acuity and resolution of distortion.Conclusion: Difluprednate is an effective treatment for patients with severe pseudophakic cystoid macular edema. SD-OCT allows the physician to monitor resolution of the macular edema easily.Keywords: cystoid macular edema, difluprednate, spectral domain optical coherence tomography, pseudophakic
format article
author Chalam KV
Khetpal V
Patel CJ
author_facet Chalam KV
Khetpal V
Patel CJ
author_sort Chalam KV
title Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate
title_short Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate
title_full Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate
title_fullStr Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate
title_full_unstemmed Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate
title_sort spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/1fb01691647247e4878168f7d59b23cd
work_keys_str_mv AT chalamkv spectraldomainopticalcoherencetomographydocumentedrapidresolutionofpseudophakiccystoidmacularedemawithtopicaldifluprednate
AT khetpalv spectraldomainopticalcoherencetomographydocumentedrapidresolutionofpseudophakiccystoidmacularedemawithtopicaldifluprednate
AT patelcj spectraldomainopticalcoherencetomographydocumentedrapidresolutionofpseudophakiccystoidmacularedemawithtopicaldifluprednate
_version_ 1718402696960016384